(Q35960876)

11 August 2017

1 reference

title

Use and interpretation of HCV diagnostic tests in the clinical setting (English)

1 reference

11 August 2017

Gretch DR

1

1 reference

11 August 2017

language of work or name

1 reference

1 November 1997

1 reference

11 August 2017

published in

Clinics in liver disease

1 reference

11 August 2017

volume

1

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

543-57, vi

1 reference

Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

The use of a recombinant immunoblot assay in the interpretation of anti- hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Impact of specimen handling and storage on detection of hepatitis C virus RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Comparative evaluation of supplemental hepatitis C virus antibody test systems

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Evaluation of third-generation screening and confirmatory assays for HCV antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

E2 and NS5: new antigens for detection of hepatitis C virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

Reliability of polymerase chain reaction for detection of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970320-2

7 January 2021

10.1016/S1089-3261(05)70320-2

Identifiers

DOI

1 reference

11 August 2017

1 reference